S'abonner

SARS-CoV-2 Infection and Increased Risk for Pediatric Stroke - 20/11/22

Doi : 10.1016/j.pediatrneurol.2022.10.003 
MaryGlen J. Vielleux, MD a, b, Shanna Swartwood, MD a, b, Dan Nguyen, MD c, Karen E. James, MD d, Bree Barbeau, MPH e, Joshua L. Bonkowsky, MD, PhD a, b,
a Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine 
b Brain and Spine Center, Primary Children's Hospital, Intermountain Healthcare 
c Department of Neurology, University of Utah School of Medicine 
d Division of Pediatric Rheumatology, Department of Pediatrics, University of Utah School of Medicine 
e Disease Response, Evaluation, Analysis, & Monitoring Program, Bureau of Epidemiology, Utah Department of Health 

Communications should be addressed to: Dr. Bonkowsky; Division of Pediatric Neurology; Department of Pediatrics; University of Utah School of Medicine; 295 Chipeta Way; Salt Lake City, Utah 84108.Division of Pediatric NeurologyDepartment of PediatricsUniversity of Utah School of Medicine295 Chipeta WaySalt Lake CityUtah84108

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Sunday 20 November 2022
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

There is an increased risk of stroke in adults with severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019 [COVID-19]) infection, but whether there is a similar association with stroke in children is unclear. Our objective was to determine whether there is a correlation between COVID-19 infection, multisystem inflammatory syndrome in children (MIS-C), and pediatric ischemic stroke.

Methods

This was a retrospective, population-based cohort analysis between March 1, 2020, and June 30, 2021, conducted at a children's hospital. Pediatric patients with a diagnosis of ischemic stroke were identified using ICD-10 diagnoses of ischemic stroke, cerebrovascular accident, or cerebral infarction.

Results

We identified 16 patients, seven male and nine female, with ischemic stroke. Ages were 8 months to 17 years (median 11.5 years). More Asian (6%) and black (13%) patients had strokes compared with population prevalence (2% each, respectively). No patients had active COVID-19 infection. COVID-19 antibodies were identified in five of 11 patients tested (45%), of whom three were diagnosed with MIS-C. 82% of the strokes occurred between February and May 2021. The peak incidence was in February 2021, which was two months after peak incidence of pediatric cases of COVID-19 and one month after the peak of MIS-C cases.

Conclusions

Our study suggests that prior COVID-19 infection, but not acute infection, is correlated with a risk for stroke in the pediatric population. The risk for stroke appears to be distinct from the risk for MIS-C.

Le texte complet de cet article est disponible en PDF.

Keywords : Coronavirus, COVID-19, Pediatric, Ischemic, Stroke, MIS-C


Plan


 Conflict of Interest Disclosures: The authors have no conflicts of interest relevant to this article to disclose.
 Funding: No funding to report.
 Contributors' Statement: Drs. Vielleux, Swartwood, Nguyen, and James and Ms. Barbeau collected data, carried out the analyses, and reviewed and revised the manuscript. Dr. Bonkowsky conceptualized and designed the study, coordinated and supervised data collection, and drafted the initial manuscript. All authors provided edits to the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.